Mohini Ranganathan

5.9k total citations
88 papers, 3.7k citations indexed

About

Mohini Ranganathan is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Mohini Ranganathan has authored 88 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pharmacology, 39 papers in Cellular and Molecular Neuroscience and 17 papers in Cognitive Neuroscience. Recurrent topics in Mohini Ranganathan's work include Cannabis and Cannabinoid Research (46 papers), Neuroscience and Neuropharmacology Research (24 papers) and Neurotransmitter Receptor Influence on Behavior (22 papers). Mohini Ranganathan is often cited by papers focused on Cannabis and Cannabinoid Research (46 papers), Neuroscience and Neuropharmacology Research (24 papers) and Neurotransmitter Receptor Influence on Behavior (22 papers). Mohini Ranganathan collaborates with scholars based in United States, United Kingdom and Canada. Mohini Ranganathan's co-authors include Deepak Cyril D’Souza, R. Andrew Sewell, Brian Pittman, Patrick D. Skosnik, Rajiv Radhakrishnan, John H. Krystal, Douglas L. Boggs, Jose Cortes-Briones, Mohamed Sherif and Edward Perry and has published in prestigious journals such as NeuroImage, American Journal of Psychiatry and Journal of The Electrochemical Society.

In The Last Decade

Mohini Ranganathan

87 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohini Ranganathan United States	33	2.4k	1.7k	888	566	459	88	3.7k
Paul D. Morrison United Kingdom	24	2.4k 1.0×	1.4k 0.8×	729 0.8×	841 1.5×	439 1.0×	40	3.4k
Jonathon C. Arnold Australia	46	3.4k 1.4×	2.1k 1.3×	730 0.8×	563 1.0×	385 0.8×	135	5.2k
Matthijs G. Bossong Netherlands	31	1.8k 0.7×	1.3k 0.7×	903 1.0×	822 1.5×	379 0.8×	71	3.3k
Dagmar Koethe Germany	34	2.2k 0.9×	1.4k 0.8×	753 0.8×	969 1.7×	351 0.8×	64	4.6k
Philip Robson United Kingdom	22	3.1k 1.3×	1.1k 0.6×	738 0.8×	509 0.9×	571 1.2×	36	4.0k
Richard De La Garza United States	39	807 0.3×	2.0k 1.2×	677 0.8×	575 1.0×	526 1.1×	143	4.1k
Patrick D. Skosnik United States	31	1.1k 0.5×	1.0k 0.6×	793 0.9×	355 0.6×	376 0.8×	63	2.5k
Thomas F. Newton United States	39	973 0.4×	2.1k 1.3×	1.4k 1.6×	929 1.6×	586 1.3×	123	4.7k
Isabelle Boileau Canada	37	893 0.4×	2.7k 1.6×	1.2k 1.3×	821 1.5×	735 1.6×	127	5.0k
Luca Steardo Italy	42	2.0k 0.8×	1.8k 1.1×	508 0.6×	336 0.6×	543 1.2×	137	5.8k

Countries citing papers authored by Mohini Ranganathan

Since Specialization

Citations

This map shows the geographic impact of Mohini Ranganathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohini Ranganathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohini Ranganathan more than expected).

Fields of papers citing papers by Mohini Ranganathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohini Ranganathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohini Ranganathan. The network helps show where Mohini Ranganathan may publish in the future.

Co-authorship network of co-authors of Mohini Ranganathan

This figure shows the co-authorship network connecting the top 25 collaborators of Mohini Ranganathan. A scholar is included among the top collaborators of Mohini Ranganathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohini Ranganathan. Mohini Ranganathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pfeiffer, P., Dara Ganoczy, William S. Gilmer, et al.. (2024). Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health System. The Journal of Clinical Psychiatry. 85(1). 3 indexed citations

Pittman, Brian, et al.. (2024). Sex differences in the acute effects of oral THC: a randomized, placebo-controlled, crossover human laboratory study. Psychopharmacology. 241(10). 2145–2155. 3 indexed citations

Surti, Toral, Mohini Ranganathan, Jason Johannesen, et al.. (2023). Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia. Schizophrenia Research. 256. 36–43. 7 indexed citations

Ganesh, Suhas, TuKiet T. Lam, Rolando García-Milian, et al.. (2023). Peripheral signature of altered synaptic integrity in young onset cannabis use disorder: A proteomic study of circulating extracellular vesicles. The World Journal of Biological Psychiatry. 24(7). 603–613. 4 indexed citations

Radhakrishnan, Rajiv, Patrick D. Worhunsky, Ming‐Qiang Zheng, et al.. (2022). Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PET. NeuroImage. 264. 119674–119674. 6 indexed citations

D’Souza, Deepak Cyril, et al.. (2022). Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder. Neuropsychopharmacology. 47(10). 1854–1862. 87 indexed citations

Ranganathan, Mohini, Suhas Ganesh, Deepak Cyril D’Souza, et al.. (2021). Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia. The World Journal of Biological Psychiatry. 23(1). 33–45. 32 indexed citations

Radhakrishnan, Rajiv, Patrick D. Skosnik, Mohini Ranganathan, et al.. (2021). In vivo evidence of lower synaptic vesicle density in schizophrenia. Molecular Psychiatry. 26(12). 7690–7698. 61 indexed citations

Duggal, Mona, Venkatesan Chakrapani, Lauren Liberti, et al.. (2018). Acceptability of Mobile Phone-Based Nurse-Delivered Counseling Intervention to Improve HIV Treatment Adherence and Self-Care Behaviors Among HIV-Positive Women in India. AIDS Patient Care and STDs. 32(9). 349–359. 15 indexed citations

10.

D’Souza, Deepak Cyril, Rajiv Radhakrishnan, Mohamed Sherif, et al.. (2017). Cannabinoids and Psychosis. Current Pharmaceutical Design. 22(42). 6380–6391. 30 indexed citations

11.

Boggs, Douglas L., Toral Surti, Irina Esterlis, et al.. (2017). Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the “self-medication” hypothesis in schizophrenia. Schizophrenia Research. 194. 62–69. 29 indexed citations

12.

Sherif, Mohamed, Rajiv Radhakrishnan, Deepak Cyril D’Souza, & Mohini Ranganathan. (2016). Human Laboratory Studies on Cannabinoids and Psychosis. Biological Psychiatry. 79(7). 526–538. 91 indexed citations

13.

Ranganathan, Mohini, et al.. (2016). Sublingual atropine in the treatment of clozapine-induced sialorrhea. Schizophrenia Research. 182. 144–145. 21 indexed citations

14.

Cortes-Briones, Jose, John D. Cahill, Patrick D. Skosnik, et al.. (2015). The Psychosis-like Effects of Δ9-Tetrahydrocannabinol Are Associated With Increased Cortical Noise in Healthy Humans. Biological Psychiatry. 78(11). 805–813. 37 indexed citations

15.

D’Souza, Deepak Cyril, Daniel J. Fridberg, Patrick D. Skosnik, et al.. (2012). Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ9-THC in Humans. Neuropsychopharmacology. 37(7). 1632–1646. 84 indexed citations

16.

D’Souza, Deepak Cyril, Kyung-Heup Ahn, Savita G. Bhakta, et al.. (2012). Nicotine Fails to Attenuate Ketamine-Induced Cognitive Deficits and Negative and Positive Symptoms in Humans: Implications for Schizophrenia. Biological Psychiatry. 72(9). 785–794. 30 indexed citations

17.

Ranganathan, Mohini, Michelle Carbuto, Gabriel Braley, et al.. (2012). Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans. The International Journal of Neuropsychopharmacology. 15(9). 1251–1264. 21 indexed citations

18.

D’Souza, Deepak Cyril, R. Andrew Sewell, & Mohini Ranganathan. (2009). Cannabis and psychosis/schizophrenia: human studies. European Archives of Psychiatry and Clinical Neuroscience. 259(7). 413–431. 191 indexed citations

19.

Ranganathan, Mohini, Gabriel Braley, Brian Pittman, et al.. (2008). The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology. 203(4). 737–744. 89 indexed citations

20.

Padmanabhapillai, Ajayan, Yongqiang Tang, Mohini Ranganathan, et al.. (2006). Evoked gamma band response in male adolescent subjects at high risk for alcoholism during a visual oddball task. International Journal of Psychophysiology. 62(2). 262–271. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact